FrancophonIA/ELRC3.0 huggingface dataset:
English: Ireland Universal Farma, S.L., Gran Via Carlos III, 98-7a, 08028 Barcelona
Slovenian: Universal Farma, S.L., Gran Via Carlos III, 98-7a, 08028 Barcelona Španija
English: Bayer Animal Health GmbH 51368 Leverkusen Germany
Slovenian: Bayer Animal Health GmbH 51368 Leverkusen Nemčija
English: Bayer Animal Health GmbH, 51368 Leverkusen, Germany
Slovenian: Bayer Animal Health GmbH, 51368 Leverkusen, Nemčija
English: Spectron 100 mg/ml roytok na použitie v pitnej vode pre kurčatá a morkz
Slovenian: Spectron 100 mg/ml roytok na použitie v pitnej vode pre kurčatá a morkz raztopina za dajanje v vodo za pitje
English: Syvaquinol 10% belsőleges oldat
Slovenian: Syvaquinol 10% belsőleges oldat pitovni piščanci
English: This showed that when enrofloxacin is dosed as a single oral dose of 10 mg/kg bw against a less susceptible E.coli isolate with MIC of 0.5 µg/ml, in chickens, AUC/MIC was 28.8 and in turkeys AUC/MIC was 32.2.
Slovenian: Pokazala je, da je bilo razmerje AUC/MIK pri piščancih 28,8 in pri puranih 32,2, ko se je enkratni peroralni odmerek enrofloksacina 10 mg/kg telesne mase uporabil proti občutljivim izolatom E. coli z MIK 0,5 µg/ml.
English: http://www.efsa.europa.eu/en/scdocs/doc/1372.pdf 16 Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q (2009) Antibiotic resistance in Campylobacter:
Slovenian: 16 Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q (2009) Antibiotic resistance in Campylobacter: emergence, transmission and persistence.
English: Both proprietary and published data were provided to form a picture of the depletion of residues from edible tissues resulting from treatment with enrofloxacin-containing, orally-administered veterinary
Slovenian: Predloženi so bili lastniški in objavljeni podatki, ki so predstavili črpanje ostankov iz užitnih tkiv, kar je posledica zdravljenja s peroralnimi zdravili za uporabo v veterinarski medicini, ki vsebujejo enrofloksacin, v odmerku 10 mg/kg telesne mase/dan, ki se je 5 dni dajal piščancem in puranom.
English: Poultry, rabbits
Slovenian: piščanci, purani, kunci
English: Oral solution to be administered in drinking water
Slovenian: peroralna raztopina za dajanje v vodo za pitje
English: Poultry, non egglayers
Slovenian: Baytril Vet perutnina, ki ne leže jajc
English: Netherlands Laboratorios Karizoo S.A., Pol. Ind. La Borda,
Slovenian: Nizozemska Laboratorios Karizoo S.A., Pol. Ind.
English: DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION Chickens and turkeys
Slovenian: ODMERKI ZA POSAMEZNE ŽIVALSKE VRSTE TER POT(I) IN NAČIN UPORABE ZDRAVILA
English: FLOXACIN 100 mg/ml concentrado para solucion oral pollos y pavos
Slovenian: FLOXACIN 100 mg/ml concentrado para solucion oral pollos y pavos koncentrat za peroralno raztopino
English: Belgium Global Vet Health S.L.
Slovenian: Bolgarija Global Vet Health S.L.
English: UNISOL 100 mg/ml perorální roztok pro podání v pitné vodě pro kuřata a krůt
Slovenian: UNISOL 100 mg/ml perorální roztok pro podání v pitné vodě pro kuřata a krůt raztopina za dajanje v vodo za pitje piščanci - pitovni, in purani
English: E-FLOX, geriamasis tirpalas
Slovenian: E-FLOX, geriamasis tirpalas pitovni piščanci
English: Vetaflox 100 mg/ml solução oral para frangos de engorda e coelhos
Slovenian: Vetaflox 100 mg/ml solução oral para frangos de engorda e coelhos piščanci - pitovni, in kunci
English: Енрофлоксацин 10% разтвор
Slovenian: Енрофлоксацин 10% разтвор pitovni piščanci
English: Product name INN
Slovenian: Ime zdravila
English: Syvaquinol 10% Enrofloxacin 100 mg/ml
Slovenian: Syvaquinol 10% Enrofloxacin 100 mg/ml perutnina
English: MG/ML solution pour administration dans l'eau de boisson pour poulets et lapins
Slovenian: MG/ML solution pour administration dans l'eau de boisson pour poulets et lapins raztopina za dajanje v vodo za pitje piščanci (pitovni piščanci, nadomestne kokoši nesnice, starši pitovnih piščancev) in kunci
English: Luxembourg Krka d.d.
Slovenian: Luksemburg Krka d. d. Novo mesto, Šmarješka cesta 6
English: Belgium Laboratorios Karizoo S.A., Pol. Ind. La Borda,
Slovenian: Portugalska Laboratorios Karizoo S.A., Pol. Ind.
English: Romania Bayer Animal Health GmbH, 51368 Leverkusen,
Slovenian: Romunija Bayer Animal Health GmbH, 51368 Leverkusen, Nemčija
English: Germany Vetpharma Animal Health S.L.,
Slovenian: Portugalska Vetpharma Animal Health S.L.,
English: Chicken, cattle, swine, pigeons, dogs and cats
Slovenian: ENROBIOFLOX 10%, geriamasis tirpalas piščanci, govedo, svinje, golobi, psi in mačke
English: K-flox 100 mg/ml oral solution for broilers and rabbits
Slovenian: K-flox 100 mg/ml oral solution for broilers and rabbits raztopina za peroralno uporabo piščanci in kunci
English: Dolgos u. 2., 1126 Budapest, Hungary
Slovenian: 1126 Budimpešta Madžarska
English: Belgium Vetpharma Animal Health S.L.,
Slovenian: Slovaška Vetpharma Animal Health S.L.,
English: Germany Global Vet Health S.L.
Slovenian: Portugalska Global Vet Health S.L.
English: Chicken, turkey, pigeons, cattle, swine, dogs and cats
Slovenian: ENROFLOXAN 10%, geriamasis tirpalas piščanci, purani, golobi, govedo, svinje, psi in mačke
English: Netherlands Krka d.d.
Slovenian: Nizozemska Krka d. d. Novo mesto, Šmarješka cesta 6
English: Enrofloxacin 100 g/1l
Slovenian: Enrofloxacin 100 g/1l piščanci (pitovni)
English: Chicken (broilers, broiler parent animals, pullets), rabbit
Slovenian: Quinoflox piščanci (pitovni piščanci, starši pitovnih piščancev, jarkice), kunci
English: Prodirox 100 mg/ml solução oral para frangos e coelhos
Slovenian: Prodirox 100 mg/ml solução oral para frangos e coelhos piščanci - pitovni, in kunci
English: Entecavir Accord is taken once a day.
Slovenian: Zdravilo Entecavir Accord se jemlje enkrat na dan.
English: It can also be considered for children aged from 2 to 18 years but only in those with compensated liver disease.
Slovenian: Uporablja se lahko tudi pri otrocih, starih od 2 do 18 let, vendar samo pri kompenzirani bolezni jeter.
English: The full EPAR for Entecavir Accord can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Entecavir Accord je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: When treatment is considered appropriate in children, the dose depends on their body weight.
Slovenian: Kadar se oceni, da je zdravljenje pri otrocih primerno, je odmerek odvisen od njihove telesne mase.
English: What is Entecavir Accord and what is it used for?
Slovenian: Kaj je zdravilo Entecavir Accord in za kaj se uporablja?
English: The 1 mg daily dose is also used in adults with decompensated liver disease and stopping treatment is not recommended in these patients.
Slovenian: Dnevni odmerek v višini 1 mg se uporablja tudi pri odraslih z dekompenzirano boleznijo jeter, prenehanje zdravljenja pa pri teh bolnikih ni priporočljivo.
English: What measures are being taken to ensure the safe and effective use of Entecavir Accord?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Entecavir Accord?
English: The 0.5 mg dose can be taken with or without food, but the 1 mg dose must be taken at least 2 hours before or 2 hours after a meal.
Slovenian: Odmerek v višini 0,5 mg se lahko vzame s hrano ali brez nje, odmerek v višini 1 mg pa je treba vzeti vsaj dve uri pred obrokom ali dve uri po njem.
English: Because Entecavir Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Slovenian: Ker je zdravilo Entecavir Accord generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
English: Entecavir stops the virus making DNA, and prevents it from multiplying and spreading.
Slovenian: Entekavir ustavi tvorbo DNK v virusu in tako prepreči njegovo razmnoževanje in širjenje.
English: This is a summary of the European public assessment report (EPAR) for Entecavir Accord.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Entecavir Accord.
English: Studies on the benefits and risks of the active substance in the approved uses have already been carried out with the reference medicine, Baraclude, and do not need to be repeated for Entecavir Accord.
Slovenian: Študije o koristih in tveganjih zdravilne učinkovine pri odobrenih načinih uporabe so že bile izvedene z referenčnim zdravilom Baraclude, zato jih ni treba ponoviti za zdravilo Entecavir Accord.
English: Entecavir Accord can only be obtained with a prescription and is available as tablets (0.5 mg and 1 mg).
Slovenian: Predpisovanje in izdaja zdravila Entecavir Accord je le na recept, na voljo pa je v obliki tablet (0,5 mg in 1 mg).
English: As for every medicine, the company provided studies on the quality of Entecavir Accord.
Slovenian: Kot to velja za vsako zdravilo, je družba zagotovila študije o kakovosti zdravila Entecavir Accord.
English: What are the benefits and risks of Entecavir Accord?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Entecavir Accord?
English: This means that Entecavir Accord contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the European Union (EU) called Baraclude.
Slovenian: To pomeni, da vsebuje enako zdravilno učinkovino in ima enak način delovanja kot „referenčno zdravilo“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilo Baraclude.
English: Entecavir Accord entecavir
Slovenian: Entecavir Accord entekavir
English: It is used in adults with signs of ongoing liver injury (such as inflammation and fibrosis) when the liver is still working properly (compensated liver disease) and also when the liver is no longer working properly (decompensated liver disease).
Slovenian: Uporablja se pri odraslih z znaki trenutne poškodbe jeter (kot sta vnetje in fibroza), kadar ta še delujejo pravilno (kompenzirana bolezen jeter) in tudi kadar ne delujejo pravilno (dekompenzirana bolezen jeter).
English: For adults with compensated liver disease, the dose depends on whether or not the patient has been previously treated with a medicine in the same group as Entecavir Accord (a nucleoside analogue, such as lamivudine).
Slovenian: Pri odraslih s kompenzirano boleznijo jeter je odmerek odvisen od tega, ali se je bolnik predhodno že zdravil z zdravilom iz skupine, v katero spada tudi zdravilo Entecavir Accord (z nukleozidnim analogom, kot je lamivudin).
English: The European Medicines Agency concluded that, in accordance with EU requirements, Entecavir Accord has been shown to have comparable quality and to be bioequivalent to Baraclude.
Slovenian: Evropska agencija za zdravila je zaključila, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Entecavir Accord primerljivo raven kakovosti kot referenčno zdravilo Baraclude ter da mu je biološko enakovredno.
English: Patients who have not been treated before with a nucleoside analogue receive a 0.5 mg dose, while those who have received lamivudine before but whose infection is no longer responding to it are given a 1 mg dose.
Slovenian: Bolniki, ki se še niso zdravili z nukleozidnim analogom, prejmejo odmerek v višini 0,5 mg, bolniki, ki so predhodno prejemali lamivudin, a se okužba nanj ne odziva več, pa prejmejo 1-miligramski odmerek.
English: It is not intended to provide practical advice on how to use Entecavir Accord.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: The Agency recommended that Entecavir Accord be approved for use in the EU.
Slovenian: Priporočila je, da se zdravilo Entecavir Accord odobri za uporabo v EU.
English: Treatment with Entecavir Accord should be started by a doctor with experience in the management of chronic hepatitis B.
Slovenian: Zdravljenje s tem zdravilom mora uvesti zdravnik, ki ima izkušnje z zdravljenjem kroničnega hepatitisa B.
English: For more information about treatment with Entecavir Accord, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Entecavir Accord preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Entecavir Accord have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in varnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Entecavir Accord upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo.
English: Other information about Entecavir Accord
Slovenian: Druge informacije o zdravilu Entecavir Accord
English: Entecavir Accord is a medicine used to treat chronic (long-term) hepatitis B (an infectious disease of the liver, caused by the hepatitis B virus).
Slovenian: Zdravilo Entecavir Accord se uporablja za zdravljenje odraslih s kroničnim (dolgotrajnim) hepatitisom B (nalezljivo boleznijo jeter, ki jo povzroča virus hepatitisa B).
English: For practical information about using Entecavir Accord, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Entecavir Accord naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: Entecavir Accord contains the active substance entecavir and is a ‘generic medicine'.
Slovenian: Zdravilo Entecavir Accord vsebuje zdravilno učinkovino entekavir in je „generično zdravilo“.
English: Children weighing 32.6 kg and above can be given the 0.5 mg tablets, while an oral solution of entecavir may be available for children weighing less than 32.6 kg. For further information, see the package leaflet.
Slovenian: Otroci, ki tehtajo vsaj 32,6 kg, lahko prejmejo tablete z odmerkom 0,5 mg, za tiste, ki tehtajo manj od 32,6 kg, pa je lahko na voljo peroralna raztopina entekavirja.
English: Why is Entecavir Accord approved?
Slovenian: Zakaj je bilo zdravilo Entecavir Accord odobreno?
English: The active substance in Entecavir Accord, entecavir, is an antiviral belonging to the class of the nucleoside analogues.
Slovenian: Zdravilna učinkovina v zdravilu Entecavir Accord, entekavir, je protivirusna učinkovina, ki spada v razred nukleozidnih analogov.
English: Therefore, the Agency's view was that, as for Baraclude, the benefit outweighs the identified risk.
Slovenian: Zato je menila, da njegove koristi enako kot pri zdravilu Baraclude odtehtajo znana tveganja.
English: Entecavir interferes with the action of a viral enzyme, DNA polymerase, which is involved in the formation of viral DNA.
Slovenian: Entekavir zavira delovanje virusnega encima DNK-polimeraze, ki je udeležen pri tvorbi virusne DNK.
English: How has Entecavir Accord been studied?
Slovenian: Kako je bilo zdravilo Entecavir Accord raziskano?
English: How does Entecavir Accord work?
Slovenian: Kako zdravilo Entecavir Accord deluje?
English: Date of first authorisation: 12 May 1998 Date of latest renewal: 20 May 2008
Slovenian: Datum prve odobritve: 12. maj 1998 Datum zadnjega podaljšanja: 20. maj 2008
English: Exelon can be used with food, drink and alcohol.
Slovenian: Zdravilo Exelon lahko uporabljate skupaj s hrano, pijačo in alkoholom.
English: However, Exelon may be used in this patient population and close monitoring is necessary.
Slovenian: Vendar se zdravilo Exelon v tej populaciji bolnikov lahko uporabi in potrebno je natančno spremljanje.
English: If you find you have forgotten to take your dose of Exelon, wait and take the next dose at the usual time.
Slovenian: Če ugotovite, da ste pozabili vzeti odmerek zdravila Exelon, počakajte in ob običajnem času vzemite naslednji odmerek.
English: PC: [folding box only] SN: [folding box only] NN: [folding box only]
Slovenian: PC: [samo na škatli] SN: [samo na škatli] NN: [samo na škatli]
English: Can you wear your Exelon transdermal patch when you are bathing, swimming, or in the sun?
Slovenian: Se sme transdermalni obliž Exelon nositi med kopanjem in plavanjem ter na soncu?
English: The MAH shall ensure that, following discussions and agreement with the National Competent Authorities in each Member State where Exelon patch is marketed, all physicians who are expected to prescribe Exelon patch are provided with an information pack containing the following elements:
Slovenian: Imetnik dovoljenja za promet z zdravilom mora zagotoviti, da bodo po razpravi in pridobitvi soglasja nacionalnega pristojnega organa v vsaki državi članici, kjer je zdravilo Exelon obliž dostopno na trgu, vsi zdravniki, za katere se pričakuje, da bodo predpisovali zdravilo Exelon obliž, prejeli komplet navodil, ki bo vseboval sledeče:
English: Your doctor will tell you which Exelon transdermal patch is most suitable for you.
Slovenian: Zdravnik vam bo povedal, kateri transdermalni obliž Exelon je za vas najbolj primeren.
English: What Exelon is and what it is used for
Slovenian: Kaj je zdravilo Exelon in za kaj ga uporabljamo
English: It was rated as severe in ≤2.2% of patients in these studies and in ≤3.7% of patients treated with Exelon transdermal patches in a Japanese study.
Slovenian: V teh študijah so vnetje ocenili kot hudo pri ≤2,2 % bolnikov, v japonski študiji pa pri ≤3,7 % bolnikov, ki so se zdravili s transdermalnimi obliži Exelon.
English: • Tell your caregiver that you are taking Exelon.
Slovenian: • Povejte svojemu negovalcu, da jemljete zdravilo Exelon.
English: Exelon transdermal patches may cause fainting or severe confusion.
Slovenian: Transdermalni obliži Exelon lahko povzročajo omedlevico ali hudo zmedenost.
English: Your doctor will tell you what dose of Exelon to take.
Slovenian: Zdravnik vam bo povedal, kakšen odmerek zdravila Exelon morate jemati.
English: In other cases, Exelon has been discontinued (see section 4.8).
Slovenian: V drugih primerih so zdravilo Exelon ukinili (glejte poglavje 4.8).
English: Exelon patches are thin, opaque, plastic patches that stick to the skin.
Slovenian: Obliži Exelon so tanki neprozorni plastični obliži, ki jih prilepite na kožo.
English: Other medicines and Exelon
Slovenian: Druga zdravila in zdravilo Exelon
English: Exelon should not be given at the same time as other medicines with similar effects to Exelon.
Slovenian: Zdravila Exelon ne smete jemati sočasno z drugimi zdravili, ki imajo podobne učinke kot zdravilo Exelon.
English: • The patch should not be exposed to any external heat sources (e.g. excessive sunlight, saunas,
Slovenian: • Obliža se ne sme izpostavljati zunanjim virom toplote (na primer prekomernemu sončenju,
English: Misuse of the medicinal product and dosing errors with Exelon transdermal patch have resulted in serious adverse reactions; some cases have required hospitalisation, and rarely led to death (see section 4.9).
Slovenian: Zaradi nepravilne uporabe in napak pri odmerjanju zdravila Exelon je prišlo do resnih neželenih učinkov; v nekaterih primerih je bila potrebna hospitalizacija, redko pa je prišlo do smrtnega izida (glejte poglavje 4.9).
English: Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted with Exelon in patients with dementia associated with Parkinson's disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms.
Slovenian: Preglednica 3 navaja število in delež bolnikov iz specifične 24-tedenske klinične študije z zdravilom Exelon pri bolnikih z demenco, povezano s Parkinsonovo boleznijo, z vnaprej opredeljenimi neželenimi dogodki, ki lahko odražajo poslabšanje simptomov Parkinsonove bolezni.
English: Exelon is used for the treatment of adult patients with mild to moderately severe Alzheimer's dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Slovenian: Zdravilo Exelon uporabljamo za zdravljenje odraslih bolnikov z blago do zmerno hudo Alzheimerjevo demenco, to je napredujoča bolezen možganov, ki postopoma prizadene spomin in intelektualne sposobnosti ter vpliva na vedenje bolnika.
English: • Only wear one Exelon patch at a time and replace the patch with a new one after 24 hours.
Slovenian: • Nosite samo en transdermalni obliž Exelon naenkrat in ga po 24 urah zamenjajte z novim.
English: If you have not taken Exelon for more than three days, do not take the next dose until you have talked to your doctor.
Slovenian: Če zdravila Exelon niste jemali že več kot tri dni, ne vzemite naslednjega odmerka, dokler se ne pogovorite s svojim zdravnikom.
English: Patients and their caregivers must be instructed on important administration instructions for Exelon transdermal patch (see section 4.2).
Slovenian: Bolnike in njihove negovalce je treba opozoriti na pomembne napotke za uporabo transdermalnega obliža Exelon (glejte poglavje 4.2).
English: 42 transdermal patches.
Slovenian: 42 transdermalnih obližev.
English: Care must be taken when prescribing Exelon transdermal patches:
Slovenian: Previdnost je potrebna pri predpisovanju transdermalnih obližev Exelon:
English: Switching from capsules or oral solution to transdermal patches Based on comparable exposure between oral and transdermal rivastigmine (see section 5.2), patients treated with Exelon capsules or oral solution can be switched to Exelon transdermal patches as follows:
Slovenian: Prehod z zdravljenja s kapsulami ali peroralno raztopino na zdravljenje z obliži Glede na to, da je izpostavljenost rivastigminu primerljiva pri peroralni in transdermalni aplikaciji (glejte poglavje 5.2), lahko bolniki, ki se zdravijo s kapsulami ali peroralno raztopino Exelon, preidejo na zdravljenje s transdermalnimi obliži Exelon na naslednji način:
English: Exelon 9 mg/5 cm 2, 18 mg/10 cm and 27 mg/15 cm transdermal patches are individually packaged in child-resistant, heat-sealed sachets made of a paper/polyethyleneterephthalate/aluminum/polyacrylnitrile (PAN) multi-laminated material (paper/PET/alu/PAN) or in heat-sealed, child-resistant sachets made of multi-layer composite laminate consisting of paper/polyethylene terephthalate/polyethylene/aluminum/polyamide (paper/PET/PE/alu/PA).
Slovenian: Transdermalni obliži Exelon jakosti 9 mg/5 cm 2, 18 mg/10 cm in 27 mg/15 cm so posamično pakirani v za otroke varne, toplotno zavarjene vrečke, narejene iz multilaminatnega materiala iz papirja/polietilen tereftalata/aluminija/poliakrilonitrila (PAN) (papir/PET/alu/PAN) ali v toplotno zavarjene, za otroke varne vrečke, narejene iz večplastne kompozitne folije iz papirja/polietilen tereftalata/polietilena/aluminija/poliamida (papir/PET/PE/alu/PA).
English: If you have not applied a patch for more than three days, do not apply the next one before you have talked to your doctor.
Slovenian: Če obliža niste namestili več kot tri dni, ne nameščajte naslednjega, dokler se ne pogovorite s svojim zdravnikom.
English: • Take Exelon twice a day, in the morning and evening, with food.
Slovenian: • Zdravilo Exelon jemljite s hrano dvakrat na dan, zjutraj in zvečer.
English: However, these events did not occur at a higher frequency with Exelon 13.3 mg/24 h transdermal patches than with placebo.
Slovenian: Vendar pa se ti dogodki niso pojavljali pogosteje pri uporabi transdermalnega obliža Exelon 13,3 mg/24 h v primerjavi s placebom.
English: If you stop using Exelon Tell your doctor or pharmacist if you stop using the patch.
Slovenian: Če ste prenehali uporabljati zdravilo Exelon Svojemu zdravniku povejte, če ste prenehali uporabljati obliže.
English: Some people who have accidentally taken too much Exelon have experienced feeling sick (nausea), being sick (vomiting), diarrhoea, high blood pressure and hallucinations.
Slovenian: Pri nekaterih ljudeh, ki so nehote vzeli preveč zdravila Exelon, je prišlo do navzee (slabosti s siljenjem na bruhanje), bruhanja, driske, visokega krvnega tlaka in halucinacij.
English: Absorption of rivastigmine from Exelon transdermal patches is slow.
Slovenian: Rivastigmin se iz transdermalnih obližev Exelon absorbira počasi.